Last updated 2025-12-02
Pharmacy Valuation
A pharmacy typically sells for 2x to 4x seller's discretionary earnings (SDE) or 4x to 8x EBITDA, based on comparable M&A transaction data from recent business sales. These valuation multiples reflect how buyers in this sector assess risk-adjusted returns, accounting for industry-specific profit margins, customer concentration, revenue predictability, and operational complexity. Businesses that demonstrate strong earnings stability, low owner dependency, and defensible market positioning consistently trade at the upper end of these ranges, while those with volatile cash flows or heavy reliance on a single owner tend toward the lower bound.
Industry Insight
Independent pharmacy valuations are driven by prescription volume, 340B program participation, and the mix of front-end retail versus prescription revenue. Pharmacies enrolled in the 340B Drug Pricing Program can earn margins 3-5x higher on qualifying prescriptions, significantly boosting SDE and corresponding multiples. PBM (pharmacy benefit manager) reimbursement rate trends are a critical risk factor: declining DIR (direct and indirect remuneration) fees have compressed margins industry-wide, making pharmacies with diversified revenue from compounding, long-term care, or clinical services more attractive to buyers.
Key Takeaway
A pharmacy sells for 2x to 4x SDE or 4x to 8x EBITDA, based on comparable M&A transactions. Profitability, growth rate, customer concentration, and owner dependency determine where a specific business falls within these ranges. See detailed pharmacy value estimates by revenue size.
SDE Multiple
3x
2x – 4x range
EBITDA Multiple
6x
4x – 8x range
Revenue Multiple
0.5x
0.3x – 0.7x range
Industry average net margin: ~12% | Average annual growth: ~3%
What Makes a Pharmacy Worth More (or Less)
Where your pharmacy falls within the 2x to 4x SDE range depends on five healthcare-specific factors that buyers evaluate during due diligence. Strengthening these areas before listing can materially increase your sale price. When you run a valuation with your actual financials, our calculator adjusts the baseline multiple based on exactly these factors.
Active Patient Base and New Patient Flow
The number of active patients seen within the past 18 months and the monthly new-patient acquisition rate are the primary value determinants. A practice generating 30+ new patients per month commands premium multiples.
Insurance Panel Mix and Reimbursement Rates
A diversified payer mix across commercial insurance, Medicare, and self-pay reduces revenue concentration risk. Practices overly dependent on a single insurer face valuation discounts if that contract is renegotiated.
Provider Credentials and Specializations
Board certifications, specialty credentials, and a multi-provider staffing model reduce the risk that revenue disappears when the selling provider exits. Solo-practitioner dependency is the most common value detractor.
Clinical Equipment and Technology
Modern diagnostic equipment, digital imaging systems, and electronic health records signal a practice that requires less near-term capital investment, which buyers factor into their offer price.
Compliance Record and Accreditation
Clean regulatory history, HIPAA compliance documentation, and current accreditations reduce due diligence friction and give buyers confidence that no hidden liabilities will surface post-closing.
The industry average net margin for pharmacy businesses is approximately 12% with annual sector growth of roughly 3%. Businesses that consistently exceed these benchmarks tend to command multiples closer to 4x SDE.
Example: Valuing a Pharmacy
Worked examples anchor abstract multiples to concrete dollar amounts, making it easier to understand what your business might be worth. The scenario below applies this industry's median SDE, EBITDA, and revenue multiples to a hypothetical pharmacy with $1.5M in annual revenue, illustrating how each valuation method produces a different estimate of fair market value.
Revenue: $1,500,000
Cost of Goods Sold: $600,000
Operating Expenses: $550,000
Owner Compensation: $150,000
Owner Perks: $25,000
Depreciation: $30,000
SDE: $555,000 (Net Income + Owner Comp + Perks + D&A)
EBITDA: $380,000 (Revenue - COGS - OpEx + D&A)
SDE Valuation: $555,000 x 3x = $1,665,000
EBITDA Valuation: $380,000 x 6x = $2,280,000
Revenue Valuation: $1,500,000 x 0.5x = $750,000
Pharmacy Valuation Resources
The multiples and value drivers above provide the foundation for understanding what a pharmacy is worth. For a deeper analysis of your specific situation, explore these related resources.
How Much Is a Pharmacy Worth?
Detailed value estimates by revenue size, three valuation methods explained, and category-specific factors that affect your sale price.
How to Sell a Pharmacy
Step-by-step selling process, typical timeline, common mistakes to avoid, and what buyers look for during due diligence.
For formal use (SBA loan applications, partner buyouts, or broker listings), our professional valuation reports provide a PDF document with full methodology, comparable transaction benchmarks, and risk-adjusted scenarios that lenders and advisors require.
How Pharmacy Multiples Compare
At 3x median SDE, pharmacy valuations sit above the small-business average of roughly 2.5x SDE, reflecting stronger earnings stability, recurring revenue characteristics, or higher barriers to entry in this sector. Exploring multiples across all industries helps business owners benchmark their sector against adjacent markets and understand what buyers in different categories are willing to pay.
If your business operates across multiple verticals, for example a pharmacy that also generates revenue from ancillary services, the blended valuation should weight each revenue stream by the appropriate industry multiple. Our estimate your value with our calculator handles this automatically when you select your primary industry and enter your financials.
Frequently Asked Questions
What is a good valuation multiple for a pharmacy?
A good SDE multiple for a pharmacy is 3x, within a typical range of 2x to 4x. Larger pharmacy operations with hired management use EBITDA multiples of 4x to 8x instead. Where a specific business falls within these ranges depends on profitability, growth trajectory, customer concentration, and owner dependency relative to industry benchmarks.
How many times earnings is a pharmacy worth?
A pharmacy is typically worth 2x to 4x seller's discretionary earnings (SDE) for owner-operated businesses, or 4x to 8x EBITDA for professionally managed operations. As a revenue cross-check, pharmacy businesses trade at 0.3x to 0.7x annual revenue. The earnings multiple a buyer applies depends on how transferable, predictable, and defensible the earnings stream is.
What is the rule of thumb for valuing a pharmacy?
The most common rule of thumb is to multiply seller's discretionary earnings by 3x (the industry median). For a pharmacy generating $500,000 in SDE, that produces an estimated value of $1,500,000. Rules of thumb are starting points, not final answers. A proper valuation uses at least three methods (SDE multiples, EBITDA multiples, and revenue multiples) and adjusts for risk factors specific to the individual business.
What factors affect the value of a pharmacy?
The primary factors that move a pharmacy valuation within the 2x to 4x SDE range are profit margins relative to the 12% industry average, revenue growth compared to the 3% sector norm, customer concentration (whether any single client exceeds 15% of revenue), owner dependency (whether the business operates without the current owner), and the quality of financial records and documented standard operating procedures.
What is the difference between SDE and EBITDA for pharmacy valuation?
SDE (seller's discretionary earnings) adds back the owner's total compensation and personal benefits to net income, measuring the full cash flow available to an owner-operator. EBITDA does not add back owner compensation, making it the standard for pharmacy businesses with hired management or revenue above $5 million. Most pharmacy businesses under $5 million revenue are valued on SDE multiples of 2x to 4x. Larger operations use EBITDA multiples of 4x to 8x.
Calculate Your Pharmacy Value
Use our free calculator with pharmacy multiples pre-loaded. Enter your actual financial data for a personalized estimate based on SDE, EBITDA, and revenue methods calibrated to the healthcare sector.
Value My Pharmacy for FreeRelated Healthcare Valuations
Businesses in the healthcare sector share similar valuation dynamics but differ in margins, growth rates, and buyer demand. Compare these related industries or browse all 52+ industry sectors to see the full spectrum of valuation multiples.